Why do premature newborn infants display elevated blood adenosine levels?

Area of Science:

• Neonatology
• Neuroscience
• Biochemistry

Background:

• Very low birth weight (VLBW) infants exhibit elevated blood adenosine levels, correlating with their degree of prematurity.
• Oxygen therapy for VLBW infants is under revision due to its role in retinopathy (ROP) and periventricular white matter lesions (PWMI).

Purpose of the Study:

• To investigate the mechanisms behind increased adenosine levels in VLBW infants.
• To explore the potential role of oxygen exposure and associated oxidative stress in adenosine production.
• To assess adenosine as a potential biomarker for prematurity risk and guide oxygen administration strategies.

Main Methods:

• Preliminary data analysis of blood adenosine levels in VLBW infants.
• Hypothesizing mechanisms involving brain axon activity and endothelial cell ATP synthesis.
• Reviewing established knowledge on adenosine's role in oligodendrocyte progenitor cell (OPC) differentiation and synaptic function.

Main Results:

• Preliminary data show a positive correlation between blood adenosine levels and prematurity in VLBW infants.
• Two potential sources for elevated adenosine are proposed: activity-dependent release from immature brain axons and ecto-cellular ATP conversion in endothelial cells.
• Premature exposure to oxygen may trigger extra-mitochondrial oxidative phosphorylation in axons and endothelium, contributing to adenosine production.

Conclusions:

• Elevated blood adenosine in VLBW infants may stem from immature brain development and premature response to oxygen.
• Adenosine could serve as a valuable biomarker for assessing prematurity risk.
• Findings may inform optimal oxygen administration protocols for VLBW infants, providing a molecular basis for assessment.